Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celprogen
Torrance, California, United Statescelprogen.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Commercial
01
Overview
Celprogen develops over-the-counter research products (cell lines, media), custom development services for drug discovery partners, and preclinical R&D in regenerative medicine. No clinical trial results or late-stage programs have been reported.
- Therapeutic areas
- OncologyCardiovascularMetabolic DisordersNeurology
- Modalities
- Stem cells (including cancer stem cells and iPSCs)Cell-based assaysMolecular diagnosticsCustom cell lines and mediaELISA/protein/DNA/cellular assay systems
- Industry
- Non-Drug Biotech
02
Partnerships
Academic partnerships for drug discovery mentioned generally; no specific major pharma partnerships disclosed.
Beyond the preview
Go deeper on Celprogen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Celprogen.